Pennsylvania legislation · 2025-2026 Regular Session
Pennsylvania HB1652: An Act amending the act of September 9, 1965 (P.L.497, No.251), known as the Newborn Child Testing Act, further providing for Newborn Child Screening and Follow-up Program.
Status: Signed into law, October 22, 2026
What the bill says
An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for Newborn Child Screening and Follow-up Program.
From the introduced text, June 24, 2025:
An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for Newborn Child Screening and Follow-up Program. The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows: Section 1. Section 3(a)(1) of the act of September 9, 1965 (P.L.497, No.251), known as the Newborn Child Testing Act, is amended by adding a subparagraph to read: Section 3. Newborn Child Screening and Follow-up Program.-- (a) In order to assist health care providers to determine whether treatment or other services are necessary to avert intellectual disability, physical disability or death, the department, with the approval of the Newborn Screening and Follow-up Technical Advisory Board, shall establish a program providing for: (1) The screening tests of newborn children and follow-up services for the following diseases: * * * (xi) Gaucher disease. * * * Section 2. This act shall take effect in 60 days. 20250HB1652PN2005 - 2 -
Sponsors
- Abigail Salisbury (D, 34) · primary sponsor
- Jeanne McNeill (D, 133)
- Carol Hill-Evans (D, 95)
- Carol Kazeem (D, 159)
- Dan Frankel (D, 23)
- Benjamin Sanchez (D, 153)
- Hanbidge, Liz (D, 61)
- Lisa Borowski (D, 168)
- Justin Fleming (D, 105)
- Joseph Ciresi (D, 146)
- Nikki Rivera (D, 96)
- Benjamin Waxman (D, 182)
Latest actions
- : Act No. 73 of 2026, Oct. 22, 2026
- : Approved by the Governor, Oct. 22, 2026
- : Presented to the Governor, Oct. 22, 2026
- : Signed in Senate, Oct. 22, 2026
- : Signed in House, Oct. 21, 2026
- : Third consideration and final passage, Oct. 21, 2026 (50-0)
- : Re-reported as committed, Oct. 20, 2026
- : Re-referred to APPROPRIATIONS, Oct. 20, 2026
- : Second consideration, Oct. 20, 2026
- : First consideration, Oct. 19, 2026
Votes
- Senate Floor: HB1652, RC 587 (October 21, 2026): 50 yea, 0 nay, passed
- Senate Appropriations: Re-Reported as Committed (October 20, 2026): 22 yea, 0 nay, passed
- Senate Health & Human Services: Reported as Committed (October 19, 2026): 13 yea, 0 nay, passed
- House Floor: HB1652, RC 1436 (October 5, 2026): 195 yea, 7 nay, passed
- House Appropriations: Re-report Bill As Committed (October 5, 2026): 37 yea, 0 nay, passed
- House Health: Report Bill As Committed (November 18, 2025): 26 yea, 0 nay, passed
Subjects: HEALTH
Common questions
- What is HB1652?
- HB1652 is a bill in the Pennsylvania Legislature (2025-2026 Regular Session): An Act amending the act of September 9, 1965 (P.L.497, No.251), known as the Newborn Child Testing Act, further providing for Newborn Child Screening and Follow-up Program.
- What does HB1652 do?
- In its own words: An act requiring physicians, hospitals and other institutions to administer or cause to be administered tests for genetic diseases upon infants in certain cases," further providing for Newborn Child Screening and Follow-up Program.
- What is the status of HB1652?
- Signed into law as of October 22, 2026. Latest action: Act No. 73 of 2026, Oct. 22, 2026 (October 22, 2026).
- Who sponsored HB1652?
- Abigail Salisbury (D, 34), with 11 co-sponsors.
- Where is the official record for HB1652?
- On the Pennsylvania Legislature website: https://www.palegis.us/legislation/bills/2025/hb1652
Source: official Pennsylvania record. Tracked by Delilah, AI for legislation across all 50 states and Congress.